Lab21
Novacyt H1 Sales Spike Sharply
Company highlights during the first half of 2017 include China approval for Novaprep for non-gynecological cancer testing, and a €3 million private financing round.
Novacyt Completes €3M Fundraising
The clinical diagnostics company will use the funds to invest in a new UK-based manufacturing facility and to accelerate global growth.
MDxHealth Inks UK Distribution Deal for Prostate Cancer Test
Lab21 will serve as a non-exclusive distributor of the SelectMDx prostate cancer test in the UK.
Novacyt Raises $3.8M in Private Equity
Novacyt announced a €3.1 million ($3.8 million) private equity placement to open new markets and develop infectious disease diagnostics.
Study Demonstrates Molecular Testing Superior to ELISA for Diagnosing Invasive Aspergillosis
Premium
NEW YORK (GenomeWeb) — Molecular testing methods such as nucleic acid sequence-based amplification (NASBA) and qPCR, administered either in combination or separately, are superior to routinely used ELISA-based assays for diagnosing invasive aspergillosis, according to a newly published retrospect
Oct 17, 2013
Feb 28, 2013
Feb 28, 2013
Feb 6, 2013
Jan 15, 2013
Selah Genomics Buys EnGenCore
Oct 15, 2012
BD, Lab21 Team on Oncology Assays
Jul 9, 2012
Clydesdale Bank Invests $7.8M into Lab21
Apr 12, 2012
Feb 24, 2012